Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY:SYK)

389.94 +8.33 (+2.18%)
Official Closing Price Updated: 7:00 PM EDT, Aug 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stryker announces definitive agreement for the sale of its U.S. spinal implants business and plans to sell related international business
From Stryker Corporation
Via GlobeNewswire
Stryker reports 2024 operating results and 2025 outlook
From Stryker Corporation
Via GlobeNewswire
Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.
From Stryker Corporation
Via GlobeNewswire
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today
 
Via Benzinga
How Is The Market Feeling About Stryker?
 
Via Benzinga
Here's How Much You Would Have Made Owning Stryker Stock In The Last 20 Years
 
Via Benzinga
How Is The Market Feeling About Stryker?
 
Via Benzinga
Earnings Scheduled For January 28, 2025
 
Via Benzinga
Stryker Had A Good Year Last Year; Here's How It's Looking For 2025
Reflecting its strong growth, on Monday the Relative Strength (RS) Rating for Stryker stock got an upgrade from 70 to 74. 
Via Investor's Business Daily
Here's How Much You Would Have Made Owning Stryker Stock In The Last 10 Years
 
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For Stryker
 
Via Benzinga
Analyst Expectations For Stryker's Future
 
Via Benzinga
Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio?
These mid-cap stocks had impressive gains last week, including Inari Medical, Unifirst Corporation, and Walgreens. Are they in your portfolio? 
Via Benzinga
Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism Position
Stryker acquires Inari Medical in a $4.9 billion deal, enhancing its vascular portfolio with innovative VTE treatments and a growing global reach. 
Via Benzinga
Why Inari Medical Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment
From Stryker Corporation
Via GlobeNewswire
Inari Medical Catapults 30% On Rumored Stryker Takeover
Inari is best-known for its series of catheter-like devices that remove blood clots. 
Via Investor's Business Daily
Stryker to announce financial results for its fourth quarter and full year 2024
From Stryker Corporation
Via GlobeNewswire
3 Stocks Helping to Bring AI to Healthcare
Many profitable companies are using AI to make healthcare more efficient; and these companies are rewarding investors with share price growth and dividends 
Via MarketBeat
Topics Artificial Intelligence
Top 10 Dividend Champions
Via Talk Markets
Topics Stocks / Equities
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
These companies have ingrained competitive advantages in an evergreen industry backed by decades of dividend growth. 
Via The Motley Fool
Why Healthcare Providers Are Increasingly Trusting Artificial Intelligence for Detection & Diagnosis
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NYSE:MDT),(NYSE:SYK),(NASDAQ:PEGA) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence Climate Change
PepsiCo To Rally Over 17%? Here Are 10 Top Analyst Forecasts For Thursday
 
Via Benzinga
Stryker declares an $0.84 per share quarterly dividend
From Stryker Corporation
Via GlobeNewswire
Why Healthcare Providers Are Increasingly Trusting Artificial Intelligence for Detection & Diagnosis
From FN Media Group LLC
Via GlobeNewswire
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges. 
Via Benzinga
This Gap Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
 
Via Benzinga
Based on good technical signals, STRYKER CORP is potentially setting up for a breakout.
STRYKER CORP (NYSE:SYK) Reveals Intriguing Technical Aspects. Here's What You Need to Know. 
Via Chartmill
Jim Cramer Likes Cava Group, Calls This Utilities Stock 'Terrific'
On Oct. 29, Citigroup analyst Jon Tower maintained Cava Group with a Neutral and raised the price target from $115 to $140. 
Via Benzinga
Stryker reports third quarter 2024 operating results
From Stryker Corporation
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.